GlassScriptPhysician profile
John F Berry
NPI 1578524930
$9,621.49
in general payments reported to CMS, 2019-2025
24 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $2,979 · 2021: $2,444 · 2022: $1,885 · 2023: $179 · 2024: $318 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.83 |
| Education | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,375.92 | 2019-2022 | |
| Tactile Systems Technology INC | $740.59 | 2022-2025 | Flexitouch Plus, Nimbl, Flexitouch Plus |
| Boston Scientific Corporation | $280.19 | 2019-2025 | Varithena Administration Pack, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.32 | 2019-2022 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Abbvie INC. | $100.29 | 2023-2025 | |
| Medtronic Vascular, INC. | $94.96 | 2019 | |
| Abbott Laboratories | $92.66 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.03 | 2019 | |
| Merz North America, INC. | $76.94 | 2022 | |
| Conmed Corporation | $70.00 | 2023 | Conmed Hemostasis, Conmed Biliary |
| Galderma Laboratories, L.P. | $68.37 | 2022-2024 | |
| Pfizer INC. | $64.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $58.55 | 2019 | |
| Biocompatibles, INC. | $58.43 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $35.77 | 2019 | |
| Philips North America LLC | $28.76 | 2019 | |
| Bard Peripheral Vascular, INC. | $27.13 | 2025 | Venclose Maven Catheter |
| Janssen Pharmaceuticals, INC | $18.68 | 2019 | |
| Smith+Nephew, INC. | $18.23 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $17.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.